The BMJ investigates concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trial
Should mums-to-be have been told of safety signal around preterm birth? A debate has broken out over whether Pfizer should have told pregnant women taking part in its maternal respiratory syncytial virus (RSV) vaccine trial that a trial of a similar GSK vaccine was stopped over a safety signal around ...